New Drugs Tempt Lupin to Spend Up to $1 Billion: Corporate India

Lupin Ltd., the drugmaker founded by Indian billionaire Desh Bandhu Gupta, is seeking to acquire brands in the U.S. to expand its most profitable business, and may spend as much as $1 billion on a deal.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.